The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner

Cardiovascular Research

Volumn 101, Issue 2, 2014, Pages 247-255

  Fessner, Anne ^a   Esser, Jennifer S ^a   Bluhm, Franziska ^a   Grundmann, Sebastian ^a   Zhou, Qian ^a   Patterson, Cam ^b   Bode, Christoph ^a   Moser, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angio arteriogenesis; Gene expression; Inflammation; Ischaemia

Indexed keywords

ADENOVIRUS VECTOR; BLOCKING ANTIBODY; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 BLOCKING ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXB5; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTERY PERFUSION; ARTICLE; CAPILLARY DENSITY; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; FEMORAL ARTERY; GENE OVEREXPRESSION; HINDLIMB; HINDLIMB ISCHEMIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; LASER DOPPLER PERFUSION IMAGING; LEUKOCYTE; LIMB ISCHEMIA; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCINTIGRAPHY; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ANGIO-/ARTERIOGENESIS; GENE EXPRESSION; INFLAMMATION; ISCHAEMIA;

ADENOVIRIDAE; ANIMALS; BLOOD FLOW VELOCITY; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HINDLIMB; HOMEODOMAIN PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; INFLAMMATION MEDIATORS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECOVERY OF FUNCTION; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 84893145174     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt244     Document Type: Article

References (86)

1. Boschetto P, Beghe B, Fabbri LM, Ceconi C. Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice. Respirology 2011; 17:422-431
2. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 2003;23:1143-1151
3. Unthank JL, Fath SW, Burkhart HM, Miller SC, Dalsing MC. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ Res 1996;79: 1015-1023
4. Troidl K, Schaper W. Arteriogenesis versus angiogenesis in peripheral artery disease. Diabetes Metab Res Rev 2012;28(Suppl. 1):27-29
5. Deindl E, SchaperW. The art of arteriogenesis. Cell Biochem Biophys 2005;43:1-15
6. Bir SC, Pattillo CB, Pardue S, Kolluru GK, Docherty J, Goyette D et al. Nitrite anion stimulates ischemic arteriogenesis involvingNOmetabolism. Am J Physiol Heart Circ Physiol 2012;303:H178-H188
7. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998;101:40-50
8. TakedaY, Costa S, Delamarre E, Roncal C, Leite de OliveiraR, SquadritoMLet al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011;479:122-126
9. Cai W, Schaper W. Mechanisms of arteriogenesis. Acta Biochim Biophys Sin (Shanghai)2008;40:681-692
10. Hoefer IE, van Royen N, Buschmann IR, Piek JJ, SchaperW. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 2001;49:609-617
11. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997;80:829-837
12. Krumlauf R. Hox genes in vertebrate development. Cell 1994;78:191-201
13. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 1978;276: 565-570
14. Bahrami SB, Veiseh M, Dunn AA, Boudreau NJ. Temporal changes in Hox gene expression accompany endothelial cell differentiation of embryonic stem cells. Cell Adh Migr 2011;5:133-141
15. Gorski DH,Walsh K. The role of homeobox genes in vascular remodeling and angiogenesis. Circ Res 2000;87:865-872
16. WuY,Moser M, Bautch VL, Patterson C.HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells. Mol Cell Biol 2003;23: 5680-5691
17. Kachgal S, Mace KA, Boudreau NJ. The dual roles of homeobox genes in vascularization and wound healing. Cell Adh Migr 2012;6:457-470
18. Burridge KA, FriedmanMH. Environment and vascular bed origin influence differences in endothelial transcriptional profiles of coronary and iliac arteries. Am J Physiol Heart Circ Physiol 2010;299:H837-H846
19. Cantile M, Schiavo G, Terracciano L, Cillo C. Homeobox genes in normal and abnormal vasculogenesis. Nutr Metab Cardiovasc Dis 2008;18:651-658
20. Charboneau A, East L, Mulholland N, Rohde M, Boudreau N. Pbx1 is required for Hox D3-mediated angiogenesis. Angiogenesis 2005;8:289-296
21. Bruhl T, Urbich C, Aicher D, Acker-Palmer A, Zeiher AM, Dimmeler S. Homeobox A9transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res 2004;94:743-751
22. Bandyopadhyay S, Ashraf MZ, Daher P, HowePH, DiCorleto PE.HOXA9participates in the transcriptional activation of E-selectin in endothelial cells. Mol Cell Biol 2007;27: 4207-4216
23. Kansas GS. Selectins and their ligands: Current concepts and controversies. Blood 1996; 88:3259-3287
24. Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 1996;79:1196-1204
25. Winnik S, Klinkert M, Kurz H, Zoeller C, Heinke J,WuYet al. HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2. Cardiovasc Res 2009;83:558-565
26. Heinke J,Wehofsits L, Zhou Q, Zoeller C, Baar KM, Helbing T et al. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ Res 2008;103:804-812
27. Schmittgen TD, Livak KJ. Analyzing real-timePCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108
28. Niu J, AzferA, ZhelyabovskaO, Fatma S, Kolattukudy PE.Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor,MCP-1-induced protein (MCPIP). J Biol Chem 2008;283:14542-14551
29. Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R et al. Endothelin-1induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000;157:1703-1711
30. Limbourg A, Korff T, Napp LC, SchaperW, Drexler H, Limbourg FP. Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc 2009;4:1737-1746
31. Silvestre JS, Mallat Z, Tedgui A, Levy BI. Post-ischaemic neovascularization and inflammation. Cardiovasc Res 2008;78:242-249
32. RisauW. Angiogenesis is coming of age. Circ Res 1998;82:926-928
33. Cai WJ, Kocsis E,WuX, Rodriguez M, Luo X, SchaperWet al. Remodeling of the vascular tunica media is essential for development of collateral vessels in the canine heart. Mol Cell Biochem 2004;264:201-210
34. Wolf C, Cai WJ, Vosschulte R, Koltai S, Mousavipour D, Scholz Det al. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol 1998;30:2291-2305
35. Arroyo AG, Iruela-Arispe ML. Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res 2010;86:226-235
36. Niiyama H, Kai H, Yamamoto T, Shimada T, Sasaki K, Murohara T et al. Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J Am Coll Cardiol 2004;44:661-666
37. Brasier AR. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 2010;86:211-218
38. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011;364:656-665
39. Eltzschig HK, Eckle T. Ischemia and reperfusion - from mechanism to translation. Nat Med 2011;17:1391-1401
40. AkamM.Hoxgenes: From master genes to micromanagers. Curr Biol 1998;8:R676-R678
41. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: Function, expression and evolution. Nat Rev Genet 2009;10:252-263
42. Coffer PJ, Burgering BM. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 2004;4:889-899
43. Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 2006;99:1159-1166
44. Govind S. Control of development and immunity by rel transcription factors in Drosophila. Oncogene 1999;18:6875-6887
45. Mack JA, Maytin EV. Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice. J Invest Dermatol 2010;130:856-865
46. Bostrom K, Tintut Y, Kao SC, Stanford WP, Demer LL. HOXB7 overexpression promotes differentiation of C3H10T1/2 cells to smooth muscle cells. J Cell Biochem 2000; 78:210-221
47. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32: 2045-2051
48. Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS. Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer 2010;10:89
49. Luo J, CaiQ,WangW, Huang H, Zeng H, HeWet al. A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer. PLoS One 2012;7:e40127
50. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-478
51. Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 2011;12:551-564
52. Billet S, Bardin S, Verp S, Baudrie V, Michaud A, Conchon S et al. Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J Clin Invest 2007;117:1914-1925
53. Jacoby DS, Rader DJ. Renin-angiotensin system and atherothrombotic disease: From genes to treatment. Arch Intern Med 2003;163:1155-1164
54. Daugherty A, ManningMW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105:1605-1612
55. Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006;98:121-128
56. Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, BurnsWC, TwiggSM et al. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 2002;106:246-253
57. Candido R, Allen TJ, Lassila M, Cao Z, Thallas V, Cooper ME et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 2004;109: 1536-1542
58. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-E9
59. Vickers C, Hales P, KaushikV, Dick L, Gavin J, Tang J et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277:14838-14843
60. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B et al. Angiotensin- converting enzyme 2protects from severe acute lung failure. Nature 2005;436:112-116
61. Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 2010;122:717-728
62. Gallagher PE, FerrarioCM, Tallant EA. Regulation ofACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 2008;295:H2373-H2379
63. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE et al. Angiotensinconverting enzyme 2 is an essential regulator of heart function. Nature 2002;417: 822-828
64. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 2007;75:29-39
65. KimMA, Yang D, Kida K, Molotkova N, Yeo SJ, VarkiNet al. Effects of ACE2 inhibition in the post-myocardial infarction heart. J Card Fail 2010;16:777-785
66. Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M et al. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 2006;47:718-726
67. Nakamura K, Koibuchi N, Nishimatsu H, Higashikuni Y, Hirata Y, Kugiyama K et al. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice. Hypertens Res 2008;31:1953-1961
68. Bodiga S, Zhong JC,WangW, Basu R, Lo J, Liu GC et al. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res 2011;91:151-161
69. Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP et al. Organ-specific distribution ofACE2mRNAand correlating peptidase activity in rodents. Peptides 2005;26:1270-1277
70. Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM. Angiotensin IIAT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2005;289:H1013-H1019
71. Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC et al. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol 2008;295:H1377-H1384
72. Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S et al. Genetic Ace2deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 2010;107:888-897
73. Sata M, MaejimaY, Adachi F, Fukino K, Saiura A, Sugiura S et al.Amouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000;32:2097-2104
74. Sahara M, Sata M, Morita T, Nakamura K, Hirata Y, Nagai R. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 2007;115:509-517
75. MurasawaS, Mori Y, NozawaY, Gotoh N, Shibuya M, MasakiHet al. Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res 1998;82:1338-1348
76. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 2011;31:1506-1516
77. Song P,Wang S, He C,Wang S, Liang B, Viollet B et al. AMPKa2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells. Circ Res 2011;109:1230-1239
78. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R et al. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 2006;168:1808-1820
79. Yamada T, Kondo T, Numaguchi Y, Tsuzuki M, Matsubara T, Manabe I et al. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth musclelike progenitor cells. Arterioscler Thromb Vasc Biol 2007;27:2363-2369
80. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 2006;116: 2218-2225
81. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS(2/2)Apoe(2/2) mice are ameliorated by enalapril treatment. J Clin Invest 2000;105:451-458
82. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842-851
83. Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE2/2 mice. J Clin Invest 2008;118:183-194
84. Guo YJ, Li WH, Wu R, Xie Q, Cui LQ. ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages. Arch Med Res 2008;39:149-154
85. Yoshizumi M, Fujita Y, Izawa Y, Suzaki Y, Kyaw M, Ali N et al. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells. Exp Cell Res 2004;292:1-10
86. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 2005;11: 1330-1338